Skip to main content

Table 1 Baseline characteristics of study patients (n = 36)

From: Warfarin and fibrinolysis - a challenging combination: an observational cohort study

n (%, 95% CI)

Age (years)*

70 (62-78)

Sex; men

28 (78%, 62-89%)

Previous medical history

 

   ischaemic heart disease

21 (58%, 42-73%)

   hypertension

24 (67%, 50-80%)

   diabetes

11 (31%, 18-47%)

   myocardial infarction

17 (47%, 32-63%)

   thrombolysis

9 (25%, 14-41%)

   PCI or CABG

5 (14%, 6-29%)

   use of aspirin

2 (6%, 1-19%)

Signs before fibrinolysis

 

   cardiac arrest

10 (28%, 16-44%)

   pulmonary oedema

1 (3%, 0-15%)

   cardiogenic shock

5 (14%, 6-29%)

Warfarin

 

   prior use known before fibrinolysis

34 (94%, 81-99%)

   indication

 

atrial fibrillation

20 (55.5%, 40-70%)

cerebrovascular disease

6 (17%, 7-32%)

pulmonary embolism

1 (3%, 0-15%)

deep vein thrombosis

2 (5.5%, 1-19%)

heart valve disease

3 (8%, 2-23%)

cardiomyopathy

4 (11%, 4-26%)

  1. * = median (IQR). PCI = Percutaneous Coronary Intervention, CABG = Coronary Artery Bypass Graft Surgery.